Immunocore

IMCR | NASDAQ

Price Alert Chart Builder DCF Calculator

$32.22

+$0.04 (+0.12%)

Sep 22, 2026, 10:50 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Net Income	-26.42M	-51.09M	-34.32M	-52.54M	-180.03M	-74.09M
Depreciation & Amortization	2.43M	4.2M	3.24M	5.34M	7.59M	8.98M
Stock-Based Compensation	n/a	34.19M	25.69M	32.89M	48.89M	8.16M
Other Working Capital	366K	50.21M	16.64M	-2.81M	-18.57M	-28.27M
Other Non-Cash Items	11.94M	-6.38M	3.14M	-7.19M	15.09M	38.45M
Deferred Income Tax	11M	n/a	n/a	-3.53M	-12.69M	-13.27M
Change in Working Capital	-6.92M	45.13M	4.58M	-24.17M	-21.96M	-28.8M
Operating Cash Flow	-7.97M	26.06M	2.33M	-49.21M	-143.11M	-60.57M
Capital Expenditures	-3.23M	-5.17M	-4.29M	-2.2M	-1.39M	-3.07M
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-22.32M	-350M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	13.39M	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	44K	-925.46K	6K	106K	3.54M
Investing Cash Flow	-12.16M	-355.13M	-4.29M	-2.2M	-1.28M	467K
Debt Repayment	n/a	352.5M	n/a	n/a	n/a	45.13M
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	-15.42M	27.18M	5.93M	1.3M	-42.6M
Financial Cash Flow	9.2M	343.88M	27.18M	145.44M	288.19M	115.94M
Net Cash Flow	8.89M	13.11M	31.78M	81.39M	144.42M	55.75M
Free Cash Flow	-11.2M	20.89M	-1.97M	-51.41M	-144.49M	-63.65M
Adj. Free Cash Flow	-11.2M	-13.3M	-27.66M	-84.3M	-193.39M	-71.81M
Maintenance CapEx	n/a	n/a	n/a	n/a	-1.39M	n/a
Growth CapEx	-3.23M	-5.17M	-4.29M	-2.2M	n/a	-3.07M
Owner Earnings	-7.97M	26.06M	2.33M	-49.21M	-144.49M	-60.57M